NGF Bioenterprise is a Singapore registered company centred around its proprietary biotechnologies and Intellectual Properties (IPs) on nerve-related biomedicine, pioneering personalized-neuron platforms using induced pluripotent stem cell (iPSC) to identify the most efficacious targets and potent neuroactive compounds for preventive neuromedicine and neurotheranostics.
Our vision is to emerge as a world leader in novel neuromedicine formulation for finding and developing cures or natural solutions for leading neurological diseases.
